Therapeutic Antibodies: Development, Engineering, and Applications (Q167116): Difference between revisions

Latest revision as of 20:58, 21 September 2024

Therapeutic antibodies: developing and engineering treatments for diseases.

Language	Label	Description	Also known as
English	Therapeutic Antibodies: Development, Engineering, and Applications	Therapeutic antibodies: developing and engineering treatments for diseases.

0 references

0 references

@@ aliases / en / 0 / aliases / en / 0 @@
-Therapeutic Antibodies
@@ aliases / en / 1 / aliases / en / 1 @@
-Fc Receptors
@@ aliases / en / 2 / aliases / en / 2 @@
-Monoclonal Antibodies
@@ aliases / en / 3 / aliases / en / 3 @@
-Antibody Engineering
@@ aliases / en / 4 / aliases / en / 4 @@
-Immunoglobulin G
@@ aliases / en / 5 / aliases / en / 5 @@
-Nanobodies
@@ aliases / en / 6 / aliases / en / 6 @@
-Antibody Pharmacokinetics
@@ aliases / en / 7 / aliases / en / 7 @@
-Bispecific Antibodies
@@ aliases / en / 8 / aliases / en / 8 @@
-Glycosylation
@@ aliases / en / 9 / aliases / en / 9 @@
-Fc? Receptors
@@ description / en / description / en @@
-This cluster of papers focuses on the development, engineering, and applications of therapeutic antibodies, including their interaction with Fc receptors, monoclonal antibody therapy for cancer, antibody engineering techniques such as nanobodies and
+Therapeutic antibodies: developing and engineering treatments for diseases.
@@ Property / same as @@
-https://openalex.org/T11016
@@ Property / same as: https://openalex.org/T11016 / rank @@
-Normal rank
@@ Property / OpenAlex ID @@
+T11016
@@ Property / OpenAlex ID: T11016 / rank @@
+Normal rank